The Human Microbiology Institute, aims to investigate the role of the human microbiota in these age-related cognitive diseases and utilize this information in translational research to develop novel therapeutic approaches.
Your gift will support our research and contribute to the development of novel medicines for treating autism spectrum disorders.
The Human Microbiology Institute is working to develop novel therapeutics for diseases that cause high levels of morbidity among elderly patients, including COPD and pneumonia.
The Human Microbiology Institute has already identified several novel multipotent targets for treatment of metabolic diseases and now plans to translate these discoveries into novel drugs that become available to the millions of patients that need them.
Based on our discoveries of novel multipotent targets for treatment of cancer we are on the way to translate these discoveries into novel drugs.